VERGELLI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.838
EU - Europa 4.782
AS - Asia 2.562
SA - Sud America 242
AF - Africa 56
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.762
PL - Polonia 1.876
RU - Federazione Russa 1.099
IT - Italia 698
SG - Singapore 695
HK - Hong Kong 576
CN - Cina 573
VN - Vietnam 269
SE - Svezia 244
IE - Irlanda 242
BR - Brasile 193
KR - Corea 185
DE - Germania 126
GB - Regno Unito 122
FI - Finlandia 109
FR - Francia 93
UA - Ucraina 81
IN - India 63
CA - Canada 50
ID - Indonesia 37
BD - Bangladesh 35
AU - Australia 34
JO - Giordania 27
NL - Olanda 26
BE - Belgio 24
JP - Giappone 20
ES - Italia 17
TR - Turchia 17
CI - Costa d'Avorio 14
IQ - Iraq 13
MX - Messico 13
AR - Argentina 12
ZA - Sudafrica 10
EC - Ecuador 9
EG - Egitto 8
PK - Pakistan 8
PY - Paraguay 6
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
CH - Svizzera 4
CO - Colombia 4
NG - Nigeria 4
SC - Seychelles 4
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
Totale 13.513
Salva come PNG Salva come JPEG
Città #
Warsaw 1.873
Santa Clara 1.237
Ashburn 658
Hong Kong 511
Singapore 483
Fairfield 445
San Jose 317
Chandler 289
Dublin 241
Seattle 220
Cambridge 180
Seoul 180
Woodbridge 178
Houston 158
Beijing 147
Ann Arbor 144
Wilmington 134
Jacksonville 129
Milan 126
Florence 119
Buffalo 110
Council Bluffs 105
Hefei 95
Altamura 88
Lawrence 83
Los Angeles 82
Ho Chi Minh City 73
The Dalles 73
Princeton 71
Dallas 61
Lauterbourg 57
Hanoi 52
Rome 51
Boardman 42
Helsinki 42
Boston 41
Mumbai 41
Moscow 38
Medford 37
Munich 37
Jakarta 34
New York 32
Shanghai 32
Melbourne 31
San Diego 29
Dong Ket 27
London 24
Brussels 23
Paris 22
Tokyo 19
Clifton 16
Figino 16
Kent 16
Bologna 15
Da Nang 15
Abidjan 14
Phoenix 14
Barcelona 13
Turku 13
Frankfurt am Main 12
Hillsboro 12
Naples 12
Orem 12
Redondo Beach 12
São Paulo 12
Toronto 12
Turin 12
Austin 10
Brooklyn 10
Norwalk 10
West Jordan 10
Chicago 9
Guangzhou 9
Izmir 9
Lappeenranta 9
Manchester 9
Yubileyny 9
Baghdad 8
Groningen 8
Palermo 8
Amsterdam 7
Belo Horizonte 7
Curitiba 7
Falls Church 7
Frankfurt Am Main 7
Genoa 7
Haiphong 7
Miano 7
Vancouver 7
Fuzhou 6
Johannesburg 6
Montreal 6
Padua 6
Salt Lake City 6
Tianjin 6
Bắc Ninh 5
Cairo 5
Catania 5
Denver 5
Dhaka 5
Totale 9.791
Salva come PNG Salva come JPEG
Nome #
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 441
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 349
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 344
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 325
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 324
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 309
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 303
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 299
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 299
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 295
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 281
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 278
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 275
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 264
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 263
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 256
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 246
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 242
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 223
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 223
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 222
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 214
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 211
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 210
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 208
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 202
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 202
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 201
Cinnoline derivatives as human neutrophil elastase inhibitors 195
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 192
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 191
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 185
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 183
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 180
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 177
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 176
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 173
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 172
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 172
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 168
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 168
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 168
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 167
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 166
PDE5 Inhibitors and their applications 156
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 154
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 154
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 154
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 154
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 141
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 136
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 135
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 135
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 134
Alpha-2-agonist as analgesic agents 130
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 130
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 128
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 126
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 126
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 120
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 120
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 120
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 116
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 113
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 112
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 112
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 105
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 94
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 93
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 91
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors 65
Discovery of Potent PDE4 Inhibitors with 3(2H)-Pyridazinone Scaffold: Synthesis, In Silico Studies and In Vitro/Vivo Evaluation 12
Totale 13.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/20253.470 123 324 173 470 1.000 467 63 161 395 76 94 124
2025/20263.881 365 514 299 192 399 160 555 165 340 272 137 483
2026/202769 69 0 0 0 0 0 0 0 0 0 0 0
Totale 13.708